EZH2 contributes to breast cancer metastasis

被引:0
|
作者
Yomtoubian, Shira
Ryu, Seongho
Lee, Sharrell
Havel, Lauren
Gao, Dingcheng
Mittal, Vivek
机构
关键词
D O I
10.1158/1538-7445.AM2016-4447
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4447
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Targeting EZH2 in cancer therapy
    Yamagishi, Makoto
    Uchimaru, Kaoru
    CURRENT OPINION IN ONCOLOGY, 2017, 29 (05) : 375 - 381
  • [32] Regulation and Role of EZH2 in Cancer
    Yamaguchi, Hirohito
    Hung, Mien-Chie
    CANCER RESEARCH AND TREATMENT, 2014, 46 (03): : 209 - 222
  • [33] Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression
    Sharon Hensley Alford
    Katherine Toy
    Sofia D. Merajver
    Celina G. Kleer
    Breast Cancer Research and Treatment, 2012, 132 : 429 - 437
  • [34] EZH2: An Accomplice of Gastric Cancer
    Yu, Wuhan
    Liu, Ning
    Song, Xiaogang
    Chen, Lang
    Wang, Mancai
    Xiao, Guohui
    Li, Tengfei
    Wang, Zheyuan
    Zhang, Youcheng
    CANCERS, 2023, 15 (02)
  • [35] The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer
    Jieyu Wang
    Fangfang Zhong
    Jun Li
    Huiran Yue
    Wenzhi Li
    Xin Lu
    Journal of Translational Medicine, 21
  • [36] EZH2 mutation is associated with the development of visceral metastasis by enhancing proliferation and invasion and inhibiting apoptosis in breast cancer cells
    Wu, Fan
    Li, Nani
    Wu, Xiufeng
    Chen, Mulan
    Huang, Weiwei
    Chen, Xinhua
    Hong, Yi
    Wang, Lili
    Chen, Kan
    Lin, Lin
    You, Minjin
    Liu, Jian
    BMC CANCER, 2024, 24 (01)
  • [37] Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression
    Alford, Sharon Hensley
    Toy, Katherine
    Merajver, Sofia D.
    Kleer, Celina G.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (02) : 429 - 437
  • [38] The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer
    Wang, Jieyu
    Zhong, Fangfang
    Li, Jun
    Yue, Huiran
    Li, Wenzhi
    Lu, Xin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [39] The noncanonical role of EZH2 in cancer
    Huang, Jinhua
    Gou, Hongwei
    Yao, Jia
    Yi, Kaining
    Jin, Zhigang
    Matsuoka, Masao
    Zhao, Tiejun
    CANCER SCIENCE, 2021, 112 (04) : 1376 - 1382
  • [40] Overexpression of enhancer of zeste homolog 2 (EZH2) and focal adhesion kinase (FAK) is associated with cancer metastasis and poor prognosis in breast cancer
    Guo, Yawen
    Maimaiti, Yusufu
    Yu, Pan
    Liu, Zeming
    Chen, Chen
    Zhang, Yunke
    Yin, Xingjie
    Wang, Shan
    Xiu, Nie
    Bangxing, Huang
    Liu, Chunping
    Huang, Tao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 2672 - 2683